Have questions? Visit https://www.reddit.com/r/SNPedia

CDKN2A

From SNPedia
is agene
is mentioned by
Full namecyclin-dependent kinase inhibitor 2A
EntrezGene1029
PheGenI1029
VariationViewer1029
ClinVarCDKN2A
GeneCardsCDKN2A
dbSNP1029
DiseasesCDKN2A
SADR1029
HugeNav1029
wikipediaCDKN2A
googleCDKN2A
gopubmedCDKN2A
EVSCDKN2A
HEFalMpCDKN2A
MyGene2CDKN2A
23andMeCDKN2A
UniProtQ8N726
EnsemblENSG00000147889
OMIM600160
# SNPs78
 Max MagnitudeChromosome positionSummary
rs104894094021,971,058
rs104894095021,971,200
rs104894097521,974,757
rs104894098021,970,982
rs104894099021,971,183
rs104894104021,971,019
rs104894109021,971,192
rs1057519852021,971,030
rs1057519881021,971,111
rs1057519882021,974,678
rs1057519883021,971,120
rs1060501262021,994,138
rs1060501263021,971,001
rs1060501265021,974,676
rs1060501266021,968,347
rs1064794292021,974,760
rs113798404021,970,995
rs1151521,968,200
rs11552822021,971,109
rs121913381021,971,037
rs121913382021,971,178
rs121913383021,971,154
rs121913384021,971,097
rs121913385021,971,112
rs121913386021,971,018
rs121913387021,971,187
rs12191338821,971,121
rs121913389021,971,029
rs13785459721,971,094
rs137854598021,971,054
rs13785459921,971,093
rs1800586521,974,861
rs199907548021,974,682
rs281171021,991,924
rs308844021,968,160
rs34968276021,971,110
rs36204594021,971,180
rs372670098021,971,153
rs373120121,988,897
rs373121121,986,848
rs373121721,984,662
rs3731239021,974,219
rs3731245021,972,446
rs373124621,971,990
rs3731249021,970,917
rs398123152021,974,721
rs45476696021,970,902
rs559848002021,971,147
rs587776716521,971,115
rs587778189021,974,679
... further results

CDKN2A, also known as cyclin-dependent kinase Inhibitor 2A, is a gene on chromosome 9. The gene codes for two proteins, both acting as tumor suppressors.

Somatic mutations of CDKN2A are common in the majority of human cancers, with estimates that CDKN2a is the second most commonly inactivated gene in cancerous tissues after p53. Germline mutations of CDKN2A are associated with familial melanoma, glioblastoma and pancreatic cancer.Wikipedia

The degree to which risk for melanoma is increased due to a CDKN2A mutation considered pathogenic is unclear. As stated in [PMID 20831418OA-icon.png], published penetrance estimates through age 80 for CDKN2A mutations range as high as 67% [PMID 12072543OA-icon.png]. Researchers in the GEM Study estimated the risk for melanoma among CDKN2A mutation carriers to be 28% through age 80 [PMID 16234564OA-icon.png]. The authors of the previously cited paper ultimately settled on telling participants in their study that CDKN2A mutations conferred an overall 30–65% risk for melanoma by age 80 and could also increase the risk of a new primary melanoma.